Danaher Co. (NYSE:DHR) Shares Acquired by Trust Co of Kansas

Trust Co of Kansas boosted its position in Danaher Co. (NYSE:DHR) by 8.0% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,183 shares of the conglomerate’s stock after buying an additional 161 shares during the period. Danaher makes up about 0.2% of Trust Co of Kansas’ holdings, making the stock its 28th biggest position. Trust Co of Kansas’ holdings in Danaher were worth $501,000 at the end of the most recent reporting period.

A number of other large investors also recently bought and sold shares of the company. Coronation Fund Managers Ltd. lifted its position in Danaher by 29.9% in the second quarter. Coronation Fund Managers Ltd. now owns 6,389 shares of the conglomerate’s stock valued at $1,596,000 after purchasing an additional 1,470 shares during the period. Moors & Cabot Inc. raised its stake in shares of Danaher by 14.0% during the 2nd quarter. Moors & Cabot Inc. now owns 2,540 shares of the conglomerate’s stock worth $635,000 after buying an additional 311 shares in the last quarter. Mercer Global Advisors Inc. ADV lifted its holdings in shares of Danaher by 31.8% in the 2nd quarter. Mercer Global Advisors Inc. ADV now owns 56,282 shares of the conglomerate’s stock valued at $14,062,000 after buying an additional 13,576 shares during the period. Ieq Capital LLC boosted its stake in shares of Danaher by 16.5% in the second quarter. Ieq Capital LLC now owns 35,628 shares of the conglomerate’s stock valued at $8,902,000 after buying an additional 5,034 shares in the last quarter. Finally, Trust Investment Advisors grew its holdings in Danaher by 2.7% during the second quarter. Trust Investment Advisors now owns 2,881 shares of the conglomerate’s stock worth $720,000 after acquiring an additional 76 shares during the period. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Danaher Trading Down 1.4 %

Shares of DHR opened at $238.41 on Friday. Danaher Co. has a fifty-two week low of $222.53 and a fifty-two week high of $281.70. The company has a market capitalization of $172.20 billion, a PE ratio of 45.50, a price-to-earnings-growth ratio of 4.23 and a beta of 0.83. The stock has a fifty day moving average of $234.99 and a two-hundred day moving average of $253.37. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.01 and a current ratio of 1.37.

Danaher (NYSE:DHR) last released its earnings results on Tuesday, October 22nd. The conglomerate reported $1.71 EPS for the quarter, beating the consensus estimate of $1.57 by $0.14. The firm had revenue of $5.80 billion during the quarter, compared to analyst estimates of $5.59 billion. Danaher had a return on equity of 10.62% and a net margin of 16.39%. The business’s quarterly revenue was up 3.1% compared to the same quarter last year. During the same period in the prior year, the firm posted $2.02 earnings per share. As a group, analysts forecast that Danaher Co. will post 7.49 EPS for the current year.

Danaher Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, January 31st. Investors of record on Friday, December 27th will be issued a $0.27 dividend. The ex-dividend date of this dividend is Friday, December 27th. This represents a $1.08 dividend on an annualized basis and a yield of 0.45%. Danaher’s payout ratio is 20.61%.

Wall Street Analysts Forecast Growth

Several equities research analysts have commented on DHR shares. TD Cowen boosted their target price on shares of Danaher from $310.00 to $315.00 and gave the stock a “buy” rating in a research report on Wednesday, October 23rd. StockNews.com downgraded shares of Danaher from a “buy” rating to a “hold” rating in a report on Saturday, December 14th. Raymond James dropped their target price on shares of Danaher from $310.00 to $300.00 and set an “outperform” rating for the company in a report on Wednesday, October 23rd. Guggenheim began coverage on Danaher in a research note on Thursday, December 19th. They set a “buy” rating and a $275.00 price target on the stock. Finally, Stifel Nicolaus raised their price objective on Danaher from $250.00 to $265.00 and gave the company a “hold” rating in a research note on Wednesday, October 23rd. Six analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company. Based on data from MarketBeat.com, Danaher has an average rating of “Moderate Buy” and an average target price of $286.80.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.